Release Date: 24/05/10 10:02 Summary: Chairman's Address to Shareholders Price Sensitive: No Download Document 332.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%